HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Clennell Selected Research

Neoadjuvant Therapy

1/2020MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Clennell Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
01/2020
1Neoplasms (Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

1MK 2206IBA
01/2020
1Hormones (Hormone)IBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020

Therapy/Procedure

1Therapeutics
01/2020
1Neoadjuvant Therapy
01/2020